ASNA1

ASNA1 Full Name

arsA arsenite transporter, ATP-binding, homolog 1 (bacterial)

ASNA1 Introduction

ASNA1, also known as arsenite-translocating ATPase 1 or TRC40 (transmembrane domain recognition complex 40 kDa subunit), is a conserved ATPase that functions as the central component of the transmembrane domain recognition complex (TRC) pathway, which is responsible for the post-translational insertion of tail-anchored (TA) proteins into the endoplasmic reticulum (ER) membrane. The human ASNA1 gene is located on chromosome 19q13.33, spans approximately 12 kb, and contains 7 exons encoding a 348-amino-acid protein with a molecular weight of approximately 40 kDa. ASNA1 belongs to the ArsA ATPase family, which includes bacterial arsenite-translocating ATPases that confer resistance to arsenite, and it shares structural homology with the catalytic domain of the mini-chromosome maintenance (MCM) helicase complex. Despite its name, human ASNA1 does not transport arsenite; rather, it uses ATP hydrolysis to drive the insertion of TA proteins into the ER membrane. ASNA1 is ubiquitously expressed in all human tissues, with highest levels detected in the pancreas (particularly the islets of Langerhans), liver, kidney, and brain, reflecting its essential role in maintaining the proper localization of hundreds of TA proteins that regulate diverse cellular processes. The protein is primarily cytosolic but associates with the ER membrane through interactions with its receptor, the WRB protein (tryptophan-rich basic protein). Through its function in TA protein insertion, ASNA1 indirectly regulates insulin secretion from pancreatic beta cells, axonal development in neurons, and the cellular response to endoplasmic reticulum stress, and its dysregulation has been implicated in type 2 diabetes, neurodegenerative diseases, and certain cancers.

Figure 1. Schematic structure of ASNA1.

Molecular Function: TRC Pathway for Tail-Anchored Protein Insertion
The primary function of ASNA1 is to insert tail-anchored (TA) proteins into the endoplasmic reticulum membrane. TA proteins are a class of integral membrane proteins characterized by a single transmembrane domain (TMD) located near the C-terminus, followed by a short luminal or extracellular tail. Because the TMD is at the C-terminus, TA proteins cannot be inserted co-translationally via the Sec61 translocon; instead, they are inserted post-translationally by the TRC pathway. The TRC pathway consists of three core components: ASNA1 (the ATPase), the WRB protein (the ER membrane receptor), and CAML (calcium-modulating cyclophilin ligand, an auxiliary subunit). The insertion cycle proceeds as follows: newly synthesized TA proteins are released from the ribosome into the cytosol, where their C-terminal TMD is recognized by the chaperone SGTA (small glutamine-rich tetratricopeptide repeat-containing protein alpha), which prevents aggregation. The TA protein is then transferred to ASNA1, which binds the TMD with high affinity. ASNA1, in its open, ATP-bound conformation, delivers the TA protein to the ER membrane by interacting with the WRB/CAML receptor complex.

Role in Insulin Secretion and Diabetes
ASNA1 is essential for normal insulin secretion from pancreatic beta cells, and its dysfunction has been implicated in the pathogenesis of type 2 diabetes (T2D). Several TA proteins that depend on ASNA1 for membrane insertion are critical for insulin granule biogenesis, exocytosis, and recycling. For example, the SNARE protein syntaxin 5 is required for ER-to-Golgi transport of proinsulin, while the SNARE protein Sec22b is involved in ER-Golgi communication and autophagosome formation. Another key TA protein is BET1L, which mediates vesicle fusion at the ER-Golgi intermediate compartment. When ASNA1 is depleted in beta cell lines (INS-1, MIN6) using siRNA or shRNA, proinsulin synthesis is not affected, but its processing to mature insulin and its storage in secretory granules are severely impaired, leading to reduced glucose-stimulated insulin secretion (GSIS). In ASNA1-depleted cells, the Golgi apparatus becomes fragmented, and the trafficking of vesicles between the ER and Golgi is disrupted. In humans, genome-wide association studies (GWAS) have identified single nucleotide polymorphisms (SNPs) near or within the ASNA1 gene that are associated with fasting glucose levels, HbA1c, and type 2 diabetes risk.

Alternate Names for ASNA1

ASNA1; arsA arsenite transporter, ATP-binding, homolog 1 (bacterial); arsA (bacterial) arsenite transporter, ATP binding, homolog 1; ATPase ASNA1; ARSA I; GET3; golgi to ER traffic 3 homolog (S. cerevisiae); transmembrane domain recognition complex; 40kDa; TRC40